ELIQUENT Life Sciences
↗Washington, DC, USA
ELIQUENT Life Sciences is a global regulatory consulting firm formed through the strategic fusion of six industry-leading consultancies: Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, RApport Global, and IDEC. The firm provides integrated solutions across the entire product lifecycle, helping pharmaceutical, biotechnology, and medical device companies navigate complex regulatory, quality, and compliance landscapes.
Headquartered in Washington, D.C., and backed by GHO Capital, ELIQUENT operates on a global scale with a presence in the U.S., Europe, and the Asia-Pacific region. The company specializes in regulatory affairs, pharmacovigilance, and quality management, leveraging a high concentration of former FDA and EMA officials to provide strategic guidance and technical execution for therapy development and market authorization.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M (estimated)
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Investors:GHO Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Consultancy)
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy, RNA, Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:GHO Capital (Investor)
Subsidiaries:Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, RApport Global, IDEC
Key Partnerships:Veeva Systems (Pharmacovigilance transformation collaboration)
COMPETITION
Position:Leader
Competitors:ProPharma Group, PharmaLex, Parexel (Regulatory Consulting), Halloran Consulting Group, Azzur Group
LEADERSHIP
Key Executives:
Tim Dietlin - CEO
Steve Purtell - CFO
Rob Wojciechowski - COO / Managing Director
John Taylor - Head of Quality & Compliance
Michele Dougherty - Head of Regulatory Affairs
Board Members:Tim Dietlin, Representatives from GHO Capital
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ELIQUENT Life Sciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.